Tirzepatide May Interfere with Birth Control Pills More Than Other GLP-1 Drugs Due to Its Stronger Stomach-Slowing Effect | Research

The takeaway

Unlike other GLP-1 drugs, tirzepatide significantly reduced oral hormonal contraceptive absorption by delaying gastric emptying, raising concerns about unintended pregnancies and requiring enhanced patient counseling.

1 of 6 drugs showed interaction
Only tirzepatide (not other GLP-1 RAs) significantly reduced oral contraceptive absorption in clinical trials

What the researchers found

Tirzepatide significantly reduced oral contraceptive absorption (AUC, Cmax, and Tmax) while 5 studies of other GLP-1 RAs showed no clinically significant interaction with oral hormonal contraceptives.

Why it matters

Millions of women of reproductive age will take GLP-1 drugs for obesity and diabetes. If tirzepatide reduces birth control pill effectiveness, the consequences could be unintended pregnancies. Prescribers and patients need to know about this interaction and plan accordingly.

The numbers in context

Tirzepatide's gastric emptying delay is most substantial after the first dose, with tachyphylaxis (tolerance) developing after subsequent doses.

How the study worked

Literature review of 6 clinical trials from PubMed and Google Scholar examining interactions between incretin agents and oral hormonal contraceptives.

Who was studied

Women using oral hormonal contraceptives and GLP-1/GIP receptor agonists

What this study cannot tell us

Only 6 clinical trials available for review. The tirzepatide-contraceptive interaction was from a single study. The clinical significance of the reduced absorption (whether it actually leads to contraceptive failure) is not directly established. Other GLP-1 drugs may have less data available.

How to read the evidence

Moderate evidence from clinical trial review. The tirzepatide interaction is based on a single study, though the pharmacological mechanism is well-established.

When this study was published

Published in 2024. Highly relevant given the explosive growth of tirzepatide prescriptions.

The bigger picture

The 'Ozempic baby' phenomenon has received media attention, but the mechanism has been debated. This review clarifies that tirzepatide specifically — not all GLP-1 drugs — may interfere with oral contraceptive absorption. As tirzepatide prescriptions grow rapidly, this interaction becomes an important public health consideration.

Questions still open

Does the reduced contraceptive absorption from tirzepatide actually translate to higher pregnancy rates?
Should women on tirzepatide use non-oral contraception or additional barrier methods?
Does the gastric emptying tachyphylaxis with tirzepatide reduce the drug interaction over time?

Common questions

Can GLP-1 drugs make birth control pills less effective?

For most GLP-1 drugs (semaglutide, liraglutide, etc.), clinical trials show no significant effect on birth control pill absorption. However, tirzepatide (Mounjaro/Zepbound) appears to be different — it significantly reduces oral contraceptive absorption, potentially making the pill less reliable.

What should women on tirzepatide do about birth control?

Discuss with your doctor. Options include using non-oral contraception (IUD, implant, injection), adding backup barrier methods during dose escalation, or timing contraceptive doses carefully. The manufacturer recommends awareness of this interaction.

Read the original research

The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception.

Journal of the American Pharmacists Association : JAPhA, 64(1), 204-211.e4

View on PubMed ↗Publisher’s paper ↗

Citation

Skelley, Jessica W; Swearengin, Katelyn; York, Adriane L; Glover, Lacey H. (2024). The impact of tirzepatide and glucagon-like peptide 1 receptor agonists on oral hormonal contraception.. Journal of the American Pharmacists Association : JAPhA, 64(1), 204-211.e4. https://doi.org/10.1016/j.japh.2023.10.037